Amino Acid and Lipid Metabolism in Cancer: Mechanisms and Therapeutic Opportunities
MedComm · 2026-08 · 7 (8)
DOI: 10.1002/mco2.70886 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 19.07.2026. Verfasst von Zixu Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology Qilu Hospital of Shandong University Jinan China. Die Arbeit nennt 203 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
Metabolic reprogramming is a defining feature of cancer and a major contributor to immune escape. Beyond the well‐defined glycolysis, dysregulated amino acid and lipid metabolism also regulate tumor growth, stress adaptation, and therapeutic resistance. Amino acids such as glutamine, arginine, tryptophan, methionine, serine, and cysteine shape biosynthesis, redox balance, one‐carbon metabolism, epigenetic control, and nutrient competition in the tumor microenvironment. Lipid uptake, de novo lipogenesis, fatty acid oxidation, cholesterol remodeling, COX‐PGE2 signaling, sphingolipid metabolism, and ferroptosis further influence antigen presentation, immune cell fitness, and checkpoint regulation. However, most studies still consider these metabolic axes separately, leaving the coordinated amino acid–lipid crosstalk across tumor and immune compartments insufficiently defined. This review synthesizes recent advances in amino acid metabolism, including the glutamine axis, arginine‐polyamine biology, the tryptophan–kynurenine–AHR pathway, and methionine‐dependent methylation programs. It then discusses lipid metabolic programs that regulate dendritic cell cross‐presentation, suppressive myeloid polarization, CD8 + T cell exhaustion, PD‐L1 palmitoylation, MHC‐I stability, and lipid‐peroxidation‐linked ferroptosis. We further integrate nutrient competition, immunometabolic checkpoints, and dual metabolic targeting strategies with immune checkpoint blockade. This review provides a unified framework for identifying metabolic vulnerabilities, designing rational combination therapies and refining precision cancer immunotherapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Oncology Qilu Hospital of Shandong University Jinan China.
- Department of Gynecologic Oncology Tianjin Medical University Cancer Institute and Hospital Tianjin China.
- Department of Cancer Biology Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA.
ORCID-Profile: Kai Huang
Förderung
- Natural Science Foundation of Shandong Province
Zitieren
APA
Wang, Z., Fu, X., Bai, J., Liu, Y., & Huang, K. (2026). Amino Acid and Lipid Metabolism in Cancer: Mechanisms and Therapeutic Opportunities. MedComm, 7(8). https://doi.org/10.1002/mco2.70886
Vancouver
Wang Z, Fu X, Bai J, Liu Y, Huang K. Amino Acid and Lipid Metabolism in Cancer: Mechanisms and Therapeutic Opportunities. MedComm. 2026;7(8). doi:10.1002/mco2.70886
BibTeX
@article{Wang2026,
author = {Wang, Zixu and Fu, Xin and Bai, Jingchao and Liu, Yanguo and Huang, Kai},
title = {Amino Acid and Lipid Metabolism in Cancer: Mechanisms and Therapeutic Opportunities},
journal = {MedComm},
year = {2026},
volume = {7},
number = {8},
doi = {10.1002/mco2.70886}
}
EUVIMED